Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Eminent Venture Capital
investment firm
About
Eminent Venture Capital is a private equity fund.
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
6
0
Eminent Venture Capital has made 6 investments. Their most recent investment was on
Sep 8, 2015, when Selecta Biosciences raised $38M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 8, 2015
Selecta Biosciences
|
Series E | $38M | Biopharma | — |
|
Jan 7, 2015
Tarveda Therapeutics
|
Series B | $21M | Biotechnology | — |
|
Oct 15, 2014
Selecta Biosciences
|
Private Equity（PE） | $20M | Biopharma | — |
|
May 5, 2008
Cardiva Medical
|
Series D | $15.50M | Health Care | — |
|
Sep 26, 2007
GlobeImmune
|
Series C | $41.20M | Biotechnology | — |
Exits
Eminent Venture Capital has had 4 exits. Eminent Venture Capital most notable exits include Cardiva Medical , GlobeImmune
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 20, 2021 | Cardiva Medical | M&A | Health Care | Detail |
| Jul 5, 2016 | GlobeImmune | IPO | Biotechnology | Detail |
| Jun 22, 2016 | Selecta Biosciences | IPO | Biopharma | Detail |
| Jan 1, 2012 | Nereus Pharmaceuticals | M&A | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
